siRNA Related Product

SKU
SR30004
Trilencer-27 Universal scrambled negative control siRNA duplex - 2 nmol
  $130.00
In Stock*
Specifications
Specifications
Product Data
Quality Control This duplex was sequence verified and functionally validated.
Storage Store at -20°C.
Components
1 vial of universal scrambled negative control siRNA duplex (2 nmol)
Stability The control is stable for one year from date of shipping when stored at -20oC.
Shipping Ambient
Note Single siRNA duplex (10nmol) can be ordered.
Reference Data
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

Loss of Syndecan-3 Drives a Pro-inflammatory, EndMT-prone Phenotype in Aortic Valve Endothelial Cells
Ezeokeke, Bedford, Stroschein et al
bioRxiv (2026)
AI Summary: OriGene’s Trilencer-27 Universal scrambled negative control siRNA duplex (cat. SR30004) was used as a non-targeting control in experiments assessing the effects of syndecan-3 silencing in aortic valve endothelial cells.
Snippet: A Trilencer-27 Universal scrambled negative control siRNA duplex (Origene, cat. SR30004) was used as the non-targeting control (NTC) at the same concentration. Twenty
A targetable dependency on nonsense-mediated decay for cellular homeostasis and immune control in small cell lung cancer
Torres-Fernández, Boehm, Kaufmann et al
Mol Cancer (2026) 25 (1) DOI: 10.1186/s12943-026-02750-2
AI Summary: OriGene contributed to this study by providing the control siRNA (siCTRL, OriGene #SR30004) used for transient knockdown experiments to investigate the role of nonsense-mediated decay in small cell lung cancer.
Snippet: siRNA transfection for transient knockdown: for transient siRNA transfection, Lipofectamine RNAiMAX reagent was used at a 10pmol RNA:2μL Lipofectamine ratio following the manufacturer’s instructions with the following siRNAs: siCTRL (Origene #SR30004)
FigureFigureFigure
Ferritinophagy Contributes to Iron Accumulation and Ferroptosis in Fuchs Endothelial Corneal Dystrophy
Shepard, Skeie, Shevalye et al
bioRxiv (2026)
AI Summary: OriGene products, specifically the three distinct 27-mer siRNA duplexes against human NCOA4 (Cat# SR305344) and the universal 27-mer scrambled siRNA duplex (Cat# SR30004), were used to selectively knock down NCOA4 expression in cell culture models to investigate the role of ferritinophagy in Fuchs Endothelial Corneal Dystrophy.
Snippet: A set of three distinct 27-mer siRNA duplexes against human NCOA4 (Cat#SR305344;referred to as siRNA-A, siRNA-B, and siRNA-C) as well as a universal 27-mer scrambled siRNA duplex (Cat#SR30004;referred to as (-)siRNA) were purchased from Origene Technologies (Rockville, MD, USA). Lipofectamine RNAiMax (Cat#13778150;ThermoFisher) was used as the transfection agent for the reverse transfection of HCEC-B4G12 and F35T cells with the anti
Transcriptomic Profiling of the Effects of DDR1 in Breast and Ovarian Cancer to Understand the Association Between DDR1 Expression and Patient Survival
Alshammari, Deen, Ellis et al
Genes (2026) 17 (7), 760-760 DOI: 10.3390/genes17070760
Cited by 1
AI Summary: OriGene products, specifically DDR1 siRNA (SR319533A) and negative control siRNA (SR30004), were used to achieve DDR1 knockdown in breast and ovarian cancer cell lines, enabling the study of DDR1’s impact on gene expression and patient survival in these cancers.
Snippet: T47D and IGROV1 cells were subject to DDR1 knockdown using siRNA. Transfection was achieved using Lipofectamine 3000 in Opti-MEM reduced-serum medium (Thermo-Fisher, MA, USA) and 11.2nM siRNA (DDR1: Origene, MD, USA, SR319533A) or negative control siRNA (OriGene SR30004). Cell transfection occurred over 24 h, and knockdown was assessed at 24, 48, and 72 h post-transfection
Enhanced expression of ADAMTS1 in ovarian carcinomas: loss of ADAMTS1 expression instigates cellular reprogramming of extracellular matrix ensuing altered plasticity, augmented migration and attenuated adhesion
Escalona, King, Lokman et al
J Biomed Sci (2026) 33 (1) DOI: 10.1186/s12929-026-01260-z
AI Summary: OriGene’s Universal nontargeting siRNA duplex (SR30004) was used as a control in experiments assessing the effects of ADAMTS1 knockdown on ovarian cancer cell lines in this study.
Snippet: A (A + B + C) directed against ADAMTS1 were used to knock down ADAMTS1 expression (A-KD) in OVCAR4, OVCAR5 and ES2 cell lines. A Universal nontargeting siRNA duplex was used as a Control (C) (OriGene Technologies, SR30004, MD, USA) in these experiments. To avoid off-target effects, the lowest ADAMTS1 siRNA concentrations were optimized for each cell line (range tested was from 1 to 10 nM)
FigureFigureFigure
G3BP1 is a SWI/SNF-bound regulator of transcription that modulates activation of STATs
Papadopoulos, Sarri, Lennartsson et al
Biosci Rep (2026) 46 (5) DOI: 10.1042/BSR20250290
AI Summary: OriGene’s Trilencer-27 G3BP1 siRNA and scrambled negative control siRNA were used to transiently knock down G3BP1 expression in AG01523 cells, enabling the study of G3BP1’s role in regulating STAT signaling and gene transcription.
Snippet: AG01523 cells were transiently transfected with 20 nM siRNA of Trilencer-27 G3BP siRNA (#SR, OriGene Technologies, USA) or 20 nM scrambled negative control siRNA (#SR30004, OriGene Technologies, USA), using SilentFect reagent (BioRad), and incubated for 72 to 96 h at 37°C in a CO2 incubator
Showing 1-6 of 286 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products